Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
Status:
Withdrawn
Trial end date:
2012-03-01
Target enrollment:
Participant gender:
Summary
Type 2 diabetes mellitus significantly increases the risk for the development of
atherosclerosis. Recently, atherosclerosis imaging with 18F-FDG PET (18F-Fluorodeoxyglucose
Positron Emission Tomography) is useful for tracking inflammation within plaque and
monitoring the response to drug therapy
The purpose of this study is to determine whether FDG-PET is capable of detecting
atherosclerotic vascular inflammation and monitoring the early effects of statins in type 2
diabetic patients. The usefulness of FDG-PET in risk stratification is also investigated.